Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00168779
Status:
COMPLETED
Last Update Posted:
2017-12-28
First Post:
2005-09-12
Brief Title:
Randomized Double-Blind Placebo-Controlled Forced-Titration Comparing Telmisartan vs Valsartan Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Organization Data
Organization:
Boehringer Ingelheim
Class:
INDUSTRY
Study ID:
502476
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boehringer Ingelheim
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Boehringer Ingelheim Study Chair
Old Organization:
Boehringer Ingelheim